Innovative agents in cancer prevention.

Innovative agents in cancer prevention. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Innovative agents in cancer prevention. Abstract Text:

Margaret M Manson,Peter B Farmer,Andreas Gescher,William P Steward,

There are many facets to cancer prevention: a good diet, weight control and physical activity, a healthy environment, avoidance of carcinogens such as those in tobacco smoke, and screening of populations at risk to allow early detection. But there is also the possibility of using drugs or naturally occurring compounds to prevent initiation of, or to suppress, tumour growth. Only a few such agents have been used to date in the clinic with any success, and these include non-steroidal anti-inflammatory drugs for colon, finasteride for prostate and tamoxifen or raloxifene for breast tumours. An ideal chemopreventive agent would restore normal growth control to a preneoplastic or cancerous cell population by modifying aberrant signalling pathways or inducing apoptosis (or both) in cells beyond repair. Characteristics for such an agent include selectivity for damaged or transformed cells, good bioavailability and more than one mechanism of action to foil redundancy or crosstalk in signalling pathways. As more research effort is being targeted towards this area, the distinction between chemotherapeutic and chemopreventive agents is blurring. Chemotherapeutic drugs are now being designed to target over- or under-active signalling molecules within cancer cells, a philosophy which is just as relevant in chemoprevention. Development of dietary agents is particularly attractive because of our long-standing exposure to them, their relative lack of toxicity, and encouraging indications from epidemiology. The carcinogenic process relies on the cell's ability to proliferate abnormally, evade apoptosis, induce angiogenesis and metastasise to distant sites. In vitro studies with a number of different diet-derived compounds suggest that there are molecules capable of modulating each of these aspects of tumour growth. However, on the negative side many of them have rather poor bioavailability. The challenge is to uncover their multiple mechanisms of action in order to predict their efficacy, to learn how to use them effectively in combination, and in some cases to redesign them to improve potency or bioavailability. These ideas are illustrated by dietary agents such as indole-3-carbinol (I3C), epigallocatechin gallate (EGCG), curcumin and resveratrol, all of which appear to have a number of different molecular targets, impinging on several signalling pathways. Ultimately it may be possible not only to suppress tumours and to extend quality of life by administering appropriate diet-derived molecules, but also to refine the definition of a cancer chemopreventive diet.

Innovative agents in cancer prevention. Publishing Authors By Initials

MM Manson,PB Farmer,A Gescher,WP Steward,

For similar neoplasms research abstracts see: neoplasms research

PUBMED ID PMID:

MEDLINE DATE:

Innovative agents in cancer prevention. Journal Published:

PUBLICATION TYPE: Review

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 166

Page Numbers: 257-75

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 2005

Innovative agents in cancer prevention. Information

Number of References: 101

LANGUAGE: eng

NlmUniqueID: 44671

Innovative agents in cancer prevention. Keywords Mesh Terms:

KEYWORDS: Neoplasms

MESH TERMS: prevention & control

Chemical & Substance for Abstract: Innovative agents in cancer prevention. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for Innovative agents in cancer prevention.

AFFILIATION: Cancer Biomarkers and Prevention Group, Departments of Cancer Studies and Biochemistry, University of Leicester, LE1 7RH, UK. mmm2@le.ac.uk

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Innovative agents in cancer prevention Related Publications

• A NOTE ON THE ELECTRON STAINING OF DIFORMAZAN DEPOSITS IN TISSUE SECTIONS.
• Actin polymerization and ERK phosphorylation are required for Arc/Arg3.1 mRNA targeting to activated synaptic sites on dendrites.
• An interview with John Steward, Region 10 RVP.
• Assessment of a patient consultation questionnaire-based scoring system for stratification of outpatient risk of colorectal cancer.
• CDC recommendations for a community plan for the prevention and containment of suicide clusters.
• Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains.
• Cyclic Nitriles: Stereodivergent Addition-Alkylation-Cyclization to cis- and trans-Abietanes.
• Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.
• Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidation.
• Cyclic oxonitriles: stereodivergent grignard addition-alkylations.
• Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains.
• Dynamics of bidirectional transport of Arc mRNA in neuronal dendrites.
• Emergence of the capacity for LTP during reinnervation of the dentate gyrus: evidence that abnormally shaped spines can mediate LTP.
• Genes on distal chromosome 18 determine vulnerability to excitotoxic neurodegeneration following status epilepticus, but not striatal neurodegeneration induced by quinolinic acid.
• Image analysis techniques for holograms of dynamic oceanic particles.
• Incidence of neoplasms in children born after influenza epidemics.
• Innovative agents in cancer prevention.
• Metalated nitriles: internal 1,2-asymmetric induction.
• Metalated nitriles: internal 1,2-asymmetric induction.
• Minimally invasive video-assisted thyroidectomy.
• Need for a "team approach" to clinical and research problems of children's tumours.
• New genera of RNA viruses in subtropical seawater, inferred from polymerase gene sequences.
• Obituary: J. K. Steward.
• Oxonitriles: a grignard addition-acylation route to enamides.
• Polysynaptic activation of the dentate gyrus of the hippocampal formation: an olfactory input via the lateral entorhinal cortex.
• Recovery of forepaw gripping ability and reorganization of cortical motor control following cervical spinal cord injuries in mice.
• Sonographically-directed neck dissection for recurrent thyroid carcinoma.
• Spinal pathways involved in the control of forelimb motor function in rats.
• The ineffectiveness of mepacrine in the treatment of coccidiosis of chickens, mice and sheep.
• Trichostrongylosis and haemonchosis in the camel: their recognition and response to phenothiazine.